Patents by Inventor Xiaoqian TAO

Xiaoqian TAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230173006
    Abstract: An application of a traditional Chinese medicine composition to preparation of a medicine for treating or preventing coronavirus infection. The composition is prepared from the following raw material medicines in parts by weight: 1-3 parts of honey-fried herba ephedrae, 1-10 parts of semen armeniacae amarum, 1-6 parts of radix platycodonis, 1-6 parts of radix peucedani, 1-6 parts of bulbus fritillariae thunbergii, 1-6 parts of radix stemonae, 1-3 parts of oroxylum indicum, 1-10 parts of radix glehniae and 1-3 parts of radix glycyrrhizae. The diluent of the traditional Chinese medicine composition can protect Vero cells infected with 2019-nCov virus.
    Type: Application
    Filed: March 10, 2021
    Publication date: June 8, 2023
    Applicant: JIANGSU KANION PHARMACEUTICAL CO., LTD.
    Inventors: Wei XIAO, Xinzhuang ZHANG, Zhipeng KE, Zhenzhen SU, Xiaoqian TAO, Yi DENG, Zeyu CAO, Liang CAO, Zhenzhong WANG, Xiaolian HE, Xuehong DONG, Yanqiu WANG
  • Publication number: 20230173011
    Abstract: Application of a traditional Chinese medicine composition to preparation of a medicine for treating or preventing coronavirus infection. The traditional Chinese medicine composition includes: 2-10 parts of flos lonicerae, 2-10 parts of fructus forsythiae, 2-6 parts of herba menthae, 2-4 parts of herba schizonepetae, 2-5 parts of fermented soybean, 2-6 parts of fried arctii fructus, 2-6 parts of radix platycodonis, 2-4 parts of herba lophatheri and 2-5 parts of radix glycyrrhizae. The traditional Chinese medicine composition has a good effect of treating or preventing coronavirus-related diseases.
    Type: Application
    Filed: March 11, 2021
    Publication date: June 8, 2023
    Applicant: JIANGSU KANION PHARMACEUTICAL CO., LTD.
    Inventors: Wei XIAO, Zhenzhen SU, Xiaoqian TAO, Zhipeng KE, Xinzhuang ZHANG, Zeyu CAO, Yi DENG, Liang CAO, Zhenzhong WANG, Xiaolian HE, Xuehong DONG, Yanqiu WANG
  • Publication number: 20230158095
    Abstract: Application of a traditional Chinese medicine composition to preparation of a medicine for treating or preventing coronavirus infection. The traditional Chinese medicine composition includes: 5-30 parts of herba houttuyniae, 5-30 parts of flos lonicerae, 5-20 parts of radix paeoniae rubra, 3-15 parts of folium artemisiae argyi and 3-15 parts of herba menthae. The traditional Chinese medicine composition has a good effect of treating or preventing coronavirus-related diseases.
    Type: Application
    Filed: March 11, 2021
    Publication date: May 25, 2023
    Applicant: JIANGSU KANION PHARMACEUTICAL CO., LTD.
    Inventors: Wei XIAO, Xiaoqian TAO, Xinzhuang ZHANG, Zhenzhen SU, Zhipeng KE, Zeyu CAO, Liang CAO, Xiaolian HE, Xuehong DONG, Yanqiu WANG